Optimization of Application-Driven Development of In Vitro Neuromuscular Junction Models.

Area of Science:

• Biomedical Engineering
• Neuroscience
• Stem Cell Biology

Background:

• Neuromuscular junctions (NMJs) are critical for motor neuron and muscle communication.
• NMJ dysfunction underlies various neurological disorders, including developmental issues, toxic exposures, and neurodegeneration.
• Ethical and environmental constraints limit in vivo studies, necessitating advanced in vitro models.

Purpose of the Study:

• To review the current state-of-the-art in in vitro neuromuscular junction (NMJ) models.
• To discuss the applications of these models in understanding cell and tissue interactions.
• To highlight bioengineering advancements in recapitulating human NMJ characteristics.

Main Methods:

• Review of existing literature on NMJ prototypes and platforms.
• Analysis of stem cell differentiation techniques for NMJ modeling.
• Evaluation of bioengineering approaches, including microfabrication for 2D and 3D cultures.
• Discussion of patient-derived induced pluripotent stem cells for personalized disease modeling.

Main Results:

• Diverse NMJ models exist, tailored for developmental studies, disease modeling, and high-throughput screening.
• Stem cell differentiation and patient-derived iPSCs enable recapitulation of early development and personalized disease investigation.
• Bioengineering innovations have led to sophisticated 2D and 3D NMJ culture systems.
• Current models show promise but require further validation for broader regulatory and pharmaceutical acceptance.

Conclusions:

• In vitro NMJ models are crucial for advancing tissue engineering and understanding neurological diseases.
• These models provide platforms for drug toxicity testing and environmental exposure assessment, potentially replacing animal models.
• Standardization and harmonization of NMJ devices are needed for wider adoption and continued progress in the field.